JULIANNE EWEN: Open Payments
NPI 1275515066 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 18 payments from 11 companies in 2025. Trend: 2023 $461 · 2024 $641 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $62 |
| Abbott Laboratories | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Verona Pharma, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Wegovy, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, JARDIANCE, AIRSUPRA, Ohtuvayre, LEQVIO, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
